Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05193968 · ClinicalTrials.gov registry record · NA

Hot Flashes and Neurovascular Function in Women

A NA study of Menopause and Hot Flashes, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05193968 is a NA study of Menopause and Hot Flashes that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 9,392-participant average among 54 other Menopause trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05193968, a NA study of Menopause and Hot Flashes, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Women who experience hot flashes are at greater risk for hypertension and other cardiovascular disease. Neurovascular control mechanisms are likely to play an important role in this relationship. As such, these studies are designed to provide a major step forward in understanding the link between hot flashes and neurovascular dysfunction and, by extension, cardiovascular disease in women.

Interventions

  • DRUG Norepinephrine
  • DRUG Acetylcholine
  • DRUG Sodium Nitroprusside
  • OTHER Sympathoexcitatory stressors
  • DRUG Terbutaline

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-02-24
Est. Completion 2026-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05193968

The ClinicalTrials.gov registry entry for NCT05193968 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,392-participant average among 54 other Menopause trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Menopause appearing as the primary indexed condition, and to 5 interventions - of which Norepinephrine is the first listed.

NCT05193968 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05193968 about?

NCT05193968 is a clinical study titled "Hot Flashes and Neurovascular Function in Women". Women who experience hot flashes are at greater risk for hypertension and other cardiovascular disease. Neurovascular control mechanisms are likely to play an important role in this relationship. As such, these studies are designed to provide a major step forward in understanding the link between ho...

What is the current status of trial NCT05193968?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-02-24. Estimated completion is 2026-12.

What conditions does trial NCT05193968 study?

This clinical trial studies the following conditions: Menopause, Hot Flashes, Vasomotor System; Labile.

What interventions are being tested in trial NCT05193968?

The interventions under investigation include: Norepinephrine (DRUG), Acetylcholine (DRUG), Sodium Nitroprusside (DRUG), Sympathoexcitatory stressors (OTHER), Terbutaline (DRUG).

Who is sponsoring clinical trial NCT05193968?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05193968 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Menopause

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.